About
Marvel Biosciences Corp (V:MRVL) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 23 2026
Marvel Biosciences to Participate and Present at the 2nd Neuroscience Innovation Partnering and Licensing Summit
Apr 17 2026
Marvel Biosciences Announces Closing of Convertible Debenture Offering
Apr 16 2026
Marvel Biosciences Identifies Liquid Formulations for Neurodevelopmental Disorders
Apr 13 2026
Marvel Biosciences Announces an Amendment to the Conversion Price for Marvel's Proposed Convertible Debenture Offering
Apr 8 2026
Marvel Biosciences Announces Proposed Convertible Debenture Offering
Recent Videos
Marvel Biosciences (TSXV:MRVL) - Novel Treatment For Social Withdrawal Shows Rapid Results
Mar 19, 2026
Marvel Biosciences Nears Human Trials as MB-204 De-Risks Autism & Alzheimer’s
Jan 27, 2026
Marvel Biosciences Nears Human Trials as MB-204 De-Risks Autism & Alzheimer’s
Jan 26, 2026
Marvel Biosciences’ Mark Williams talks MB-204
Dec 22, 2025